According to a new evidence-based Viewpoint published online in Lancet Regional Health Southeast Asia, the widely used glycated haemoglobin (HbA1c) test, as available in India, may not accurately reflect blood glucose levels for millions of Indians.
Led by Professor Anoop Misra and collaborators, the review questions reliance on HbA1c as a sole diagnostic or monitoring tool for type 2 diabetes in South Asia, including India. HbA1c measurements primarily reflect the glycation of haemoglobin.